<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02610270</url>
  </required_header>
  <id_info>
    <org_study_id>CAR-2</org_study_id>
    <nct_id>NCT02610270</nct_id>
  </id_info>
  <brief_title>Erythrocyte Omega-3 Fatty Acid Content in Elite Athletes</brief_title>
  <acronym>O3Sport</acronym>
  <official_title>Erythrocyte Omega-3 Fatty Acid Content in Elite Athletes in Response to Omega-3 Supplementation: A Dose-Response</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre d'Alt Rendiment</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Centre d'Alt Rendiment</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      A suitable concentration of omega-3 fatty acids in relation to omega 6 is considered
      necessary for a good cell function and prevention of various inflammatory processes. Diet and
      supplementation are the fundamental procedures to achieve the reference values for several
      years. Athletes are individuals under physical stress and higher tissue restoration, while
      maintaining adequate diets they show, as the rest of humans, lower than desired levels. In
      the present study the investigators aims to determine the modification of those levels by the
      administration of two different doses of a given product, keeping the same model of diet and
      physical and competition.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The study aims to assess concentrations of the different fatty acids in the erythrocyte
      membrane before and after administration of a compound with high quality omega3 (EPA and DHA)
      in two different doses, compared with control group . The period of evaluation and management
      is four months, one month for the proposed renewal of red blood cells. The composition of the
      diet, the sports calendar, caloric expenditure and level of training is determined. During
      the study process it is excluded subjects with injuries or disease processes and ensure that
      no one take any supplement or modify workouts or diet.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>June 2014</start_date>
  <completion_date type="Actual">April 2015</completion_date>
  <primary_completion_date type="Actual">January 2015</primary_completion_date>
  <phase>Early Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>fatty acid levels at the membrane of the red blood cells</measure>
    <time_frame>Four months</time_frame>
    <description>Evaluation will be obtained before and after the experimental period</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Impregnation in relation to dosage administrated to the athletes</measure>
    <time_frame>Four months</time_frame>
    <description>Evaluate the impregnation level of the membrane of red blood cells, taken into account the two dosages in relation of the subjects characteristics, sex (M,F), omega3 index (EPA/DHA%), weight (kg), age(years), etc. looking for a relationships of better or worse impregnation depending on sex, body weight, body mass index, previous level of omega3, etc.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Different level of impregnation of the red blood cells in relation to dosage and weight of the athletes</measure>
    <time_frame>Four months</time_frame>
    <description>Evaluate the impregnation level of the membrane of red blood cells, taken into account the two dosages in relation of the subjects characteristics, weight (kg).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Different level of impregnation of the red blood cells in relation to dosage and different previous omega 3 index of the athletes</measure>
    <time_frame>Four months</time_frame>
    <description>Evaluate the impregnation level of the membrane of red blood cells, taken into account the two dosages in relation of the subjects characteristic of previous level of omega3 index (EPA/DHA%)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Different level of impregnation of the red blood cells in relation to dosage and different sex of the athletes</measure>
    <time_frame>Four months</time_frame>
    <description>Evaluate the impregnation level of the membrane of red blood cells, taken into account the two dosages in relation of the sex (M,F) of the subjects</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Different level of impregnation of the red blood cells in relation to dosage and different age of the athletes</measure>
    <time_frame>Four months</time_frame>
    <description>Evaluate the impregnation level of the membrane of red blood cells, taken into account the two dosages in relation of the age(years) of the subjects etc.</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">24</enrollment>
  <condition>Healthy</condition>
  <arm_group>
    <arm_group_label>2 Gums</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Athletes that continued their usual training and diet, who took 2 gums of omega 3 (DHA 760 mg) during the experimental period.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>3 Gums</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Athletes that continued their usual training and diet, who took 3 gums of omega 3 (DHA 1140 mg) during the experimental period.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Athletes and coaches that continued their usual training and diet, but did not take any supplements during the experimental period.</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>2 Gums</intervention_name>
    <description>760 mg DHA</description>
    <arm_group_label>2 Gums</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>3 Gums</intervention_name>
    <description>1140 mg DHA</description>
    <arm_group_label>3 Gums</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Healthy, young men and women athletes from the Olympic Training Center (OTC) of Sant
             Cugat del Valles in Barcelona (Spain) (20 to 45 years of age) belonging to different
             summer sport activities were asked to participate.

        Exclusion Criteria:

          -  Any type of inflammatory process, or the use of anti-inflammatory medications,
             consumption of n-3 Fatty Acids (FA) supplements and n-3 FA-supplemented foods in the
             past 3 months; planning to change dietary habits, or training schedule.

          -  During the study, any subject that falls under injury or need nonsteroidal
             antiinflammatory drug or get sick by inflammatory or infectious disease.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Franchek Drobnic, MD PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Olympic Training Center, Centre d'Alt Rendiment CAR</affiliation>
  </overall_official>
  <reference>
    <citation>Luchtman DW, Song C. Cognitive enhancement by omega-3 fatty acids from child-hood to old age: findings from animal and clinical studies. Neuropharmacology. 2013 Jan;64:550-65. doi: 10.1016/j.neuropharm.2012.07.019. Epub 2012 Jul 27. Review.</citation>
    <PMID>22841917</PMID>
  </reference>
  <reference>
    <citation>Michael-Titus AT, Priestley JV. Omega-3 fatty acids and traumatic neurological injury: from neuroprotection to neuroplasticity? Trends Neurosci. 2014 Jan;37(1):30-8. doi: 10.1016/j.tins.2013.10.005. Epub 2013 Nov 22. Review.</citation>
    <PMID>24268818</PMID>
  </reference>
  <reference>
    <citation>Yates CM, Calder PC, Ed Rainger G. Pharmacology and therapeutics of omega-3 polyunsaturated fatty acids in chronic inflammatory disease. Pharmacol Ther. 2014 Mar;141(3):272-82. doi: 10.1016/j.pharmthera.2013.10.010. Epub 2013 Nov 4. Review.</citation>
    <PMID>24201219</PMID>
  </reference>
  <reference>
    <citation>Mickleborough TD. Omega-3 polyunsaturated fatty acids in physical performance optimization. Int J Sport Nutr Exerc Metab. 2013 Feb;23(1):83-96. Review.</citation>
    <PMID>23400626</PMID>
  </reference>
  <reference>
    <citation>Bloomer RJ, Larson DE, Fisher-Wellman KH, Galpin AJ, Schilling BK. Effect of eicosapentaenoic and docosahexaenoic acid on resting and exercise-induced inflammatory and oxidative stress biomarkers: a randomized, placebo controlled, cross-over study. Lipids Health Dis. 2009 Aug 19;8:36. doi: 10.1186/1476-511X-8-36.</citation>
    <PMID>19691834</PMID>
  </reference>
  <reference>
    <citation>Lewis EJ, Radonic PW, Wolever TM, Wells GD. 21 days of mammalian omega-3 fatty acid supplementation improves aspects of neuromuscular function and performance in male athletes compared to olive oil placebo. J Int Soc Sports Nutr. 2015 Jun 18;12:28. doi: 10.1186/s12970-015-0089-4. eCollection 2015.</citation>
    <PMID>26085822</PMID>
  </reference>
  <reference>
    <citation>Bailes JE, Patel V. The potential for DHA to mitigate mild traumatic brain injury. Mil Med. 2014 Nov;179(11 Suppl):112-6. doi: 10.7205/MILMED-D-14-00139.</citation>
    <PMID>25373094</PMID>
  </reference>
  <reference>
    <citation>Hasadsri L, Wang BH, Lee JV, Erdman JW, Llano DA, Barbey AK, Wszalek T, Sharrock MF, Wang HJ. Omega-3 fatty acids as a putative treatment for traumatic brain injury. J Neurotrauma. 2013 Jun 1;30(11):897-906. doi: 10.1089/neu.2012.2672. Epub 2013 Jun 5. Review.</citation>
    <PMID>23363551</PMID>
  </reference>
  <reference>
    <citation>Di Girolamo FG, Situlin R, Mazzucco S, Valentini R, Toigo G, Biolo G. Omega-3 fatty acids and protein metabolism: enhancement of anabolic interventions for sarcopenia. Curr Opin Clin Nutr Metab Care. 2014 Mar;17(2):145-50. doi: 10.1097/MCO.0000000000000032. Review.</citation>
    <PMID>24500439</PMID>
  </reference>
  <reference>
    <citation>Skulas-Ray AC. Omega-3 fatty acids and inflammation: a perspective on the challenges of evaluating efficacy in clinical research. Prostaglandins Other Lipid Mediat. 2015 Jan-Mar;116-117:104-11. doi: 10.1016/j.prostaglandins.2015.02.001. Epub 2015 Feb 16. Review.</citation>
    <PMID>25698680</PMID>
  </reference>
  <reference>
    <citation>Harris WS, Von Schacky C. The Omega-3 Index: a new risk factor for death from coronary heart disease? Prev Med. 2004 Jul;39(1):212-20.</citation>
    <PMID>15208005</PMID>
  </reference>
  <reference>
    <citation>Enns JE, Yeganeh A, Zarychanski R, Abou-Setta AM, Friesen C, Zahradka P, Taylor CG. The impact of omega-3 polyunsaturated fatty acid supplementation on the incidence of cardiovascular events and complications in peripheral arterial disease: a systematic review and meta-analysis. BMC Cardiovasc Disord. 2014 May 31;14:70. doi: 10.1186/1471-2261-14-70. Review.</citation>
    <PMID>24885361</PMID>
  </reference>
  <reference>
    <citation>von Schacky C, Kemper M, Haslbauer R, Halle M. Low Omega-3 Index in 106 German elite winter endurance athletes: a pilot study. Int J Sport Nutr Exerc Metab. 2014 Oct;24(5):559-64. doi: 10.1123/ijsnem.2014-0041. Epub 2014 Sep 8.</citation>
    <PMID>25203220</PMID>
  </reference>
  <reference>
    <citation>Delodder F, Tappy L, Liaudet L, Schneiter P, Perrudet C, Berger MM. Incorporation and washout of n-3 PUFA after high dose intravenous and oral supplementation in healthy volunteers. Clin Nutr. 2015 Jun;34(3):400-8. doi: 10.1016/j.clnu.2014.07.005. Epub 2014 Jul 15.</citation>
    <PMID>25066733</PMID>
  </reference>
  <reference>
    <citation>Flock MR, Skulas-Ray AC, Harris WS, Etherton TD, Fleming JA, Kris-Etherton PM. Determinants of erythrocyte omega-3 fatty acid content in response to fish oil supplementation: a dose-response randomized controlled trial. J Am Heart Assoc. 2013 Nov 19;2(6):e000513. doi: 10.1161/JAHA.113.000513.</citation>
    <PMID>24252845</PMID>
  </reference>
  <reference>
    <citation>Walker CG, Browning LM, Mander AP, Madden J, West AL, Calder PC, Jebb SA. Age and sex differences in the incorporation of EPA and DHA into plasma fractions, cells and adipose tissue in humans. Br J Nutr. 2014 Feb;111(4):679-89. doi: 10.1017/S0007114513002985. Epub 2013 Sep 24.</citation>
    <PMID>24063767</PMID>
  </reference>
  <reference>
    <citation>Welch RW, Antoine JM, Berta JL, Bub A, de Vries J, Guarner F, Hasselwander O, Hendriks H, Jäkel M, Koletzko BV, Patterson CC, Richelle M, Skarp M, Theis S, Vidry S, Woodside JV; International Life Sciences Institute Europe Functional Foods Task Force. Guidelines for the design, conduct and reporting of human intervention studies to evaluate the health benefits of foods. Br J Nutr. 2011 Nov;106 Suppl 2:S3-15. doi: 10.1017/S0007114511003606.</citation>
    <PMID>22129662</PMID>
  </reference>
  <reference>
    <citation>Katan MB, Deslypere JP, van Birgelen AP, Penders M, Zegwaard M. Kinetics of the incorporation of dietary fatty acids into serum cholesteryl esters, erythrocyte membranes, and adipose tissue: an 18-month controlled study. J Lipid Res. 1997 Oct;38(10):2012-22.</citation>
    <PMID>9374124</PMID>
  </reference>
  <reference>
    <citation>Harris WS, Mozaffarian D, Lefevre M, Toner CD, Colombo J, Cunnane SC, Holden JM, Klurfeld DM, Morris MC, Whelan J. Towards establishing dietary reference intakes for eicosapentaenoic and docosahexaenoic acids. J Nutr. 2009 Apr;139(4):804S-19S. doi: 10.3945/jn.108.101329. Epub 2009 Feb 25.</citation>
    <PMID>19244379</PMID>
  </reference>
  <reference>
    <citation>Aranceta J, Pérez-Rodrigo C. Recommended dietary reference intakes, nutritional goals and dietary guidelines for fat and fatty acids: a systematic review. Br J Nutr. 2012 Jun;107 Suppl 2:S8-22. doi: 10.1017/S0007114512001444. Review.</citation>
    <PMID>22591906</PMID>
  </reference>
  <reference>
    <citation>Gómez Candela C, Bermejo López LM, Loria Kohen V. Importance of a balanced omega 6/omega 3 ratio for the maintenance of health: nutritional recommendations. Nutr Hosp. 2011 Mar-Apr;26(2):323-9. doi: 10.1590/S0212-16112011000200013. Review.</citation>
    <PMID>21666970</PMID>
  </reference>
  <reference>
    <citation>Skulas-Ray AC, Kris-Etherton PM, Harris WS, Vanden Heuvel JP, Wagner PR, West SG. Dose-response effects of omega-3 fatty acids on triglycerides, inflammation, and endothelial function in healthy persons with moderate hypertriglyceridemia. Am J Clin Nutr. 2011 Feb;93(2):243-52. doi: 10.3945/ajcn.110.003871. Epub 2010 Dec 15.</citation>
    <PMID>21159789</PMID>
  </reference>
  <reference>
    <citation>Browning LM, Walker CG, Mander AP, West AL, Madden J, Gambell JM, Young S, Wang L, Jebb SA, Calder PC. Incorporation of eicosapentaenoic and docosahexaenoic acids into lipid pools when given as supplements providing doses equivalent to typical intakes of oily fish. Am J Clin Nutr. 2012 Oct;96(4):748-58. Epub 2012 Aug 29.</citation>
    <PMID>22932281</PMID>
  </reference>
  <reference>
    <citation>Tartibian B, Maleki BH, Abbasi A. The effects of omega-3 supplementation on pulmonary function of young wrestlers during intensive training. J Sci Med Sport. 2010 Mar;13(2):281-6. doi: 10.1016/j.jsams.2008.12.634. Epub 2009 Jun 12.</citation>
    <PMID>19523875</PMID>
  </reference>
  <reference>
    <citation>Arterburn LM, Hall EB, Oken H. Distribution, interconversion, and dose response of n-3 fatty acids in humans. Am J Clin Nutr. 2006 Jun;83(6 Suppl):1467S-1476S. doi: 10.1093/ajcn/83.6.1467S. Review.</citation>
    <PMID>16841856</PMID>
  </reference>
  <reference>
    <citation>Drobnic F, CordobillaB, Rueda F, Domingo JC. Caracterización de diferentes suplementos de ácidos omega-3 en su aplicación en las edades pediátricas Acta Pediatr Esp. 2013; 71(11): e353-e357</citation>
  </reference>
  <reference>
    <citation>Cao J, Schwichtenberg KA, Hanson NQ, Tsai MY. Incorporation and clearance of omega-3 fatty acids in erythrocyte membranes and plasma phospholipids. Clin Chem. 2006 Dec;52(12):2265-72. Epub 2006 Oct 19.</citation>
    <PMID>17053155</PMID>
  </reference>
  <reference>
    <citation>Flock MR, Harris WS, Kris-Etherton PM. Long-chain omega-3 fatty acids: time to establish a dietary reference intake. Nutr Rev. 2013 Oct;71(10):692-707. doi: 10.1111/nure.12071. Epub 2013 Oct 3. Review.</citation>
    <PMID>24117792</PMID>
  </reference>
  <reference>
    <citation>Estruch R, Ros E, Salas-Salvadó J, Covas MI, Corella D, Arós F, Gómez-Gracia E, Ruiz-Gutiérrez V, Fiol M, Lapetra J, Lamuela-Raventos RM, Serra-Majem L, Pintó X, Basora J, Muñoz MA, Sorlí JV, Martínez JA, Martínez-González MA; PREDIMED Study Investigators. Primary prevention of cardiovascular disease with a Mediterranean diet. N Engl J Med. 2013 Apr 4;368(14):1279-90. doi: 10.1056/NEJMoa1200303. Epub 2013 Feb 25. Erratum in: N Engl J Med. 2014 Feb 27;370(9):886.</citation>
    <PMID>23432189</PMID>
  </reference>
  <reference>
    <citation>Lemaitre RN, Tanaka T, Tang W, Manichaikul A, Foy M, Kabagambe EK, Nettleton JA, King IB, Weng LC, Bhattacharya S, Bandinelli S, Bis JC, Rich SS, Jacobs DR Jr, Cherubini A, McKnight B, Liang S, Gu X, Rice K, Laurie CC, Lumley T, Browning BL, Psaty BM, Chen YD, Friedlander Y, Djousse L, Wu JH, Siscovick DS, Uitterlinden AG, Arnett DK, Ferrucci L, Fornage M, Tsai MY, Mozaffarian D, Steffen LM. Genetic loci associated with plasma phospholipid n-3 fatty acids: a meta-analysis of genome-wide association studies from the CHARGE Consortium. PLoS Genet. 2011 Jul;7(7):e1002193. doi: 10.1371/journal.pgen.1002193. Epub 2011 Jul 28.</citation>
    <PMID>21829377</PMID>
  </reference>
  <verification_date>November 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 13, 2015</study_first_submitted>
  <study_first_submitted_qc>November 19, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 20, 2015</study_first_posted>
  <last_update_submitted>November 19, 2015</last_update_submitted>
  <last_update_submitted_qc>November 19, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 20, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Centre d'Alt Rendiment</investigator_affiliation>
    <investigator_full_name>FRANCISCO DROBNIC, MD, PhD</investigator_full_name>
    <investigator_title>MD PhD</investigator_title>
  </responsible_party>
  <keyword>Sport</keyword>
  <keyword>fatty acid</keyword>
  <keyword>omega 3</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

